Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Early research (Phase 1)UnknownNCT04947033
What this trial is testing

A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
I-Mab Biopharma US Limited 25
Early research (Phase 1)Active Not RecruitingNCT06746688
What this trial is testing

A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer.

Who this might be right for
Breast CancerBreast Cancer Metastatic
ExpreS2ion Biotechnologies 40
Testing effectiveness (Phase 2)Looking for participantsNCT04686682
What this trial is testing

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Who this might be right for
NSCLCSCLCCRPC+5 more
Jacobio Pharmaceuticals Co., Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379596
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Who this might be right for
Gastric Cancer
AstraZeneca 452
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789327
What this trial is testing

Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors

Who this might be right for
SafetyTolerabilityEfficacy
Sichuan Huiyu Pharmaceutical Co., Ltd 254
Early research (Phase 1)Looking for participantsNCT07755436
What this trial is testing

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Who this might be right for
Ovarian CancerEndometrial CancerPlatinum-resistant Ovarian Cancer (PROC)+2 more
ArriVent BioPharma, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT06066203
What this trial is testing

GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Looking for participantsNCT07583654
What this trial is testing

Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors

Who this might be right for
mRNA VaccineSolid Tumor CancerPeptides+1 more
West China Hospital 18
Testing effectiveness (Phase 2)UnknownNCT06310382
What this trial is testing

GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results

Who this might be right for
Advanced Solid Tumors With MAPK Signal Pathway Mutations
Suzhou Genhouse Bio Co., Ltd. 110
Early research (Phase 1)Looking for participantsNCT06482905
What this trial is testing

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Who this might be right for
High-grade GliomaWHO Grade Ⅳ Glioma
Tcelltech Inc. 52
Early research (Phase 1)Looking for participantsNCT07746141
What this trial is testing

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

Who this might be right for
RAS MutationAdvanced Solid TumorMetastatic Solid Tumor
BeOne Medicines 100
Early research (Phase 1)Study completedNCT04109456
What this trial is testing

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
InxMed (Shanghai) Co., Ltd. 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Early research (Phase 1)Study completedNCT05327231
What this trial is testing

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
InxMed (Shanghai) Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT07631793
What this trial is testing

Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

Who this might be right for
Malignant Neoplasms
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 76
Early research (Phase 1)Looking for participantsNCT06508307
What this trial is testing

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

Who this might be right for
SarcomaCervical CancerColon Cancer+6 more
GONGCHU Biotechnology Co., Ltd 21
Early research (Phase 1)Ended earlyNCT05496595
What this trial is testing

DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
DynamiCure Biotechnology 5
Early research (Phase 1)Study completedNCT03733951
What this trial is testing

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 139
Next Page